BPC-157 vs TB-500: Research Comparison

BPC-157 vs TB-500

BPC-157 and TB-500 are the two most-studied peptides in preclinical repair-model research, and they are frequently investigated together. They are distinct molecules with different mechanisms. This comparison is provided for research use only (RUO).

At a Glance

	BPC-157	TB-500 (Thymosin Beta-4)
Type	Pentadecapeptide (15 aa)	Thymosin Beta-4 region (~43 aa protein)
Origin	Gastric-juice-derived sequence	Naturally occurring actin-binding peptide
Research focus	NO system, angiogenesis, GI/connective-tissue models	Actin sequestration, cell migration, tissue repair
CAS	137525-51-0	77591-33-4

BPC-157

A synthetic 15-amino-acid peptide studied in angiogenesis, nitric-oxide-system, and connective-tissue repair models. See the full BPC-157 research guide.

TB-500 (Thymosin Beta-4)

A synthetic version of a region of Thymosin Beta-4, a major actin-sequestering peptide studied in cell-migration and repair models. See the full TB-500 research guide.

Why They’re Studied Together

Because they engage different pathways (BPC-157 via NO/growth-factor signaling; TB-500 via actin regulation), the two are commonly researched as a combined “recovery” pairing — which is why they are often offered as a single blend.

Buy for Research

Zama Biosciences supplies BPC-157, TB-500, and the BPC-157 + TB-500 Blend, all independently HPLC/LC-MS tested.

Research Use Only. Not drugs, supplements, or medical devices; not for human or veterinary use, consumption, or diagnostic application. Not evaluated by the FDA.